Article: AUROBINDO PHARMA GETS US FDA NOD FOR HYPERTENSION DRUG.

NEW DELHI, July 20 Asia Pulse - Aurobindo Pharma Ltd (BSE:524804) on Friday announced it has received US Food and Drug Administration (US FDA) approval for its anti-hypertensive drug Amlodipine Besylate Tablets in multiple strengths.

The company got US FDA approval in 2.5 mg, 5 mg and 10 mg strengths, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!